Novo Integrated Sciences Ownership 2024 | Who Owns Novo Integrated Sciences Now?

Overview RevenueFinancials Chart

Institutional Ownership

4.37%

Insider Ownership

6.82%

Retail Ownership

88.81%

Institutional Holders

15.00

Novo Integrated Sciences Institutional Shareholders

Institutional Shareholders by % of Total Shares

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
BANK OF AMERICA CORP /DE/	-	-	-	-500	-100.00%	-	Dec 31, 2023
WELLS FARGO & COMPANY/MN	-	-	-	-942	-100.00%	-	Dec 31, 2023
NORTHERN TRUST CORP	-	-	-	-246,809	-100.00%	-	Dec 31, 2023
STATE STREET CORP	-	-	-	-290,192	-100.00%	-	Dec 31, 2023
VANGUARD GROUP INC	-	-	-	-1,349,380	-100.00%	-	Dec 31, 2023
MORGAN STANLEY	-	-	-	-50	-100.00%	-	Dec 31, 2023
ROYAL BANK OF CANADA	-	-	-	-75,264	-100.00%	-	Dec 31, 2023
GEODE CAPITAL MANAGEMENT, LLC	-	-	-	-1,233,520	-100.00%	-	Dec 31, 2023
MILLENNIUM MANAGEMENT LLC	-	-	-	-16,205	-100.00%	-	Dec 31, 2023
BLACKROCK INC.	-	-	-	-2,919,201	-100.00%	-	Dec 31, 2023
CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC.	-	-	-	-14,500	-100.00%	-	Dec 31, 2023
TWO SIGMA SECURITIES, LLC	-	-	-	-33,971	-100.00%	-	Dec 31, 2023
JANE STREET GROUP, LLC	-	-	-	-52,742	-100.00%	-	Dec 31, 2023
LEVEL FOUR ADVISORY SERVICES, LLC	-	-	-	-23,809	-100.00%	-	Dec 31, 2023
XTX TOPCO LTD	-	-	-	-14,096	-100.00%	-	Dec 31, 2023

Novo Integrated Sciences's largest institutional shareholder is BANK OF AMERICA CORP /DE/, holding 0.00% of the company's total share outstanding, currently valued at -. The top 10 institutional shareholders own together 0.00% of the company.

Institutional Shareholders by % of Total Assets

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
BANK OF AMERICA CORP /DE/	-	-	-	-500	-100.00%	-	Dec 31, 2023
WELLS FARGO & COMPANY/MN	-	-	-	-942	-100.00%	-	Dec 31, 2023
NORTHERN TRUST CORP	-	-	-	-246,809	-100.00%	-	Dec 31, 2023
STATE STREET CORP	-	-	-	-290,192	-100.00%	-	Dec 31, 2023
VANGUARD GROUP INC	-	-	-	-1,349,380	-100.00%	-	Dec 31, 2023
MORGAN STANLEY	-	-	-	-50	-100.00%	-	Dec 31, 2023
ROYAL BANK OF CANADA	-	-	-	-75,264	-100.00%	-	Dec 31, 2023
GEODE CAPITAL MANAGEMENT, LLC	-	-	-	-1,233,520	-100.00%	-	Dec 31, 2023
MILLENNIUM MANAGEMENT LLC	-	-	-	-16,205	-100.00%	-	Dec 31, 2023
BLACKROCK INC.	-	-	-	-2,919,201	-100.00%	-	Dec 31, 2023
CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC.	-	-	-	-14,500	-100.00%	-	Dec 31, 2023
TWO SIGMA SECURITIES, LLC	-	-	-	-33,971	-100.00%	-	Dec 31, 2023
JANE STREET GROUP, LLC	-	-	-	-52,742	-100.00%	-	Dec 31, 2023
LEVEL FOUR ADVISORY SERVICES, LLC	-	-	-	-23,809	-100.00%	-	Dec 31, 2023
XTX TOPCO LTD	-	-	-	-14,096	-100.00%	-	Dec 31, 2023

The largest Novo Integrated Sciences shareholder by % of total assets is BANK OF AMERICA CORP /DE/. The company owns 0.00 shares of Novo Integrated Sciences (NVOS), representing 0.00% of its total assets.

Institutional Buyers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
MORGAN STANLEY	-	-	-	-50	-100.00%	-	Dec 31, 2023
BANK OF AMERICA CORP /DE/	-	-	-	-500	-100.00%	-	Dec 31, 2023
WELLS FARGO & COMPANY/MN	-	-	-	-942	-100.00%	-	Dec 31, 2023
XTX TOPCO LTD	-	-	-	-14,096	-100.00%	-	Dec 31, 2023
CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC.	-	-	-	-14,500	-100.00%	-	Dec 31, 2023
MILLENNIUM MANAGEMENT LLC	-	-	-	-16,205	-100.00%	-	Dec 31, 2023
LEVEL FOUR ADVISORY SERVICES, LLC	-	-	-	-23,809	-100.00%	-	Dec 31, 2023
TWO SIGMA SECURITIES, LLC	-	-	-	-33,971	-100.00%	-	Dec 31, 2023
JANE STREET GROUP, LLC	-	-	-	-52,742	-100.00%	-	Dec 31, 2023
ROYAL BANK OF CANADA	-	-	-	-75,264	-100.00%	-	Dec 31, 2023
NORTHERN TRUST CORP	-	-	-	-246,809	-100.00%	-	Dec 31, 2023
STATE STREET CORP	-	-	-	-290,192	-100.00%	-	Dec 31, 2023
GEODE CAPITAL MANAGEMENT, LLC	-	-	-	-1,233,520	-100.00%	-	Dec 31, 2023
VANGUARD GROUP INC	-	-	-	-1,349,380	-100.00%	-	Dec 31, 2023
BLACKROCK INC.	-	-	-	-2,919,201	-100.00%	-	Dec 31, 2023

As of Dec 31 2023, Novo Integrated Sciences's largest institutional buyer is MORGAN STANLEY. The company purchased -50.00 stocks of NVOS, valued at -.

Institutional Sellers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
BLACKROCK INC.	-	-	-	-2,919,201	-100.00%	-	Dec 31, 2023
VANGUARD GROUP INC	-	-	-	-1,349,380	-100.00%	-	Dec 31, 2023
GEODE CAPITAL MANAGEMENT, LLC	-	-	-	-1,233,520	-100.00%	-	Dec 31, 2023
STATE STREET CORP	-	-	-	-290,192	-100.00%	-	Dec 31, 2023
NORTHERN TRUST CORP	-	-	-	-246,809	-100.00%	-	Dec 31, 2023
ROYAL BANK OF CANADA	-	-	-	-75,264	-100.00%	-	Dec 31, 2023
JANE STREET GROUP, LLC	-	-	-	-52,742	-100.00%	-	Dec 31, 2023
TWO SIGMA SECURITIES, LLC	-	-	-	-33,971	-100.00%	-	Dec 31, 2023
LEVEL FOUR ADVISORY SERVICES, LLC	-	-	-	-23,809	-100.00%	-	Dec 31, 2023
MILLENNIUM MANAGEMENT LLC	-	-	-	-16,205	-100.00%	-	Dec 31, 2023
CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC.	-	-	-	-14,500	-100.00%	-	Dec 31, 2023
XTX TOPCO LTD	-	-	-	-14,096	-100.00%	-	Dec 31, 2023
WELLS FARGO & COMPANY/MN	-	-	-	-942	-100.00%	-	Dec 31, 2023
BANK OF AMERICA CORP /DE/	-	-	-	-500	-100.00%	-	Dec 31, 2023
MORGAN STANLEY	-	-	-	-50	-100.00%	-	Dec 31, 2023

As of Dec 31 2023, Novo Integrated Sciences's biggest institutional seller is BLACKROCK INC.. The company sold -2.92M shares of NVOS, valued at -.

Institutional New positions

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date

Institutional Sold Out

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
BLACKROCK INC.	-	-	-	-2,919,201	-100.00%	-	Dec 31, 2023
VANGUARD GROUP INC	-	-	-	-1,349,380	-100.00%	-	Dec 31, 2023
GEODE CAPITAL MANAGEMENT, LLC	-	-	-	-1,233,520	-100.00%	-	Dec 31, 2023
STATE STREET CORP	-	-	-	-290,192	-100.00%	-	Dec 31, 2023
NORTHERN TRUST CORP	-	-	-	-246,809	-100.00%	-	Dec 31, 2023
ROYAL BANK OF CANADA	-	-	-	-75,264	-100.00%	-	Dec 31, 2023
JANE STREET GROUP, LLC	-	-	-	-52,742	-100.00%	-	Dec 31, 2023
TWO SIGMA SECURITIES, LLC	-	-	-	-33,971	-100.00%	-	Dec 31, 2023
LEVEL FOUR ADVISORY SERVICES, LLC	-	-	-	-23,809	-100.00%	-	Dec 31, 2023
MILLENNIUM MANAGEMENT LLC	-	-	-	-16,205	-100.00%	-	Dec 31, 2023
CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC.	-	-	-	-14,500	-100.00%	-	Dec 31, 2023
XTX TOPCO LTD	-	-	-	-14,096	-100.00%	-	Dec 31, 2023
WELLS FARGO & COMPANY/MN	-	-	-	-942	-100.00%	-	Dec 31, 2023
BANK OF AMERICA CORP /DE/	-	-	-	-500	-100.00%	-	Dec 31, 2023
MORGAN STANLEY	-	-	-	-50	-100.00%	-	Dec 31, 2023

Novo Integrated Sciences's largest sold out institutional shareholder by shares sold is BLACKROCK INC., sold -2.92M shares, valued at -, as of undefined.

Novo Integrated Sciences Mutual Fund Holders

Name	% Total Assets	Total Shares	Change Amount	Change %	Date
Vericimetry Funds	0.06%	5,210	-	-	Mar 31, 2024
FIDELITY CONCORD STREET TRUST	0.00%	1,040,115	-	-	Feb 29, 2024
VANGUARD INDEX FUNDS	0.00%	1,261,880	-	-	Mar 31, 2024
VANGUARD INDEX FUNDS	0.00%	240,882	-163,777	-40.47%	Mar 31, 2024
FIDELITY CONCORD STREET TRUST	0.00%	115,669	-3,512	-2.95%	Feb 29, 2024
EQ ADVISORS TRUST	0.00%	2,292	-	-	Mar 31, 2024
iSHARES TRUST	0.00%	25,590	-	-	Mar 31, 2024

Novo Integrated Sciences's largest mutual fund holder by % of total assets is "Vericimetry Funds", owning 5.21K shares, compromising 0.06% of its total assets.

Novo Integrated Sciences Institutional Ownership Trends

Institutional Holdings Trend

Date	Holdings	Change %
30 Sep, 23	15	7.14%
30 Jun, 23	14	-
31 Mar, 23	14	16.67%
31 Dec, 22	12	50.00%
30 Sep, 22	8	14.29%
30 Jun, 22	7	40.00%
31 Mar, 22	5	-28.57%
31 Dec, 21	7	40.00%
30 Sep, 21	5	-44.44%
30 Jun, 21	9	50.00%
31 Mar, 21	6	-

As of 30 Sep 23, 15 institutions are holding Novo Integrated Sciences's shares, representing an increase of 7.14% compared to the previous quarter.

Shares Outstanding Trend

Date	Shares Outstanding	Change %
30 Sep, 23	6,271,181	185.70%
30 Jun, 23	2,194,985	216.08%
31 Mar, 23	694,445	-78.66%
31 Dec, 22	3,254,104	632.08%
30 Sep, 22	444,499	4.69%
30 Jun, 22	424,580	7.15%
31 Mar, 22	396,232	-3.08%
31 Dec, 21	408,809	1.99%
30 Sep, 21	400,815	-33.50%
30 Jun, 21	602,771	446.76%
31 Mar, 21	110,244	-

Novo Integrated Sciences (NVOS) has 6.27M shares outstanding as of 30 Sep 23, up 185.70% compared to the previous quarter.

Institutional Ownership Trend

Date	Ownership %	Change %
30 Sep, 23	4.37%	57.05%
30 Jun, 23	2.77%	361.11%
31 Mar, 23	0.88%	5.20%
31 Dec, 22	4.10%	1306.59%
30 Sep, 22	0.56%	195.61%
30 Jun, 22	0.54%	214.56%
31 Mar, 22	0.50%	188.08%
31 Dec, 21	0.52%	201.88%
30 Sep, 21	0.51%	87.52%
30 Jun, 21	0.76%	3933.53%
31 Mar, 21	0.14%	-

As of 30 Sep 23, Novo Integrated Sciences is held by 4.37% institutional shareholders, representing a 57.05% growth compared to 30 Jun 23.

Institutional Increased Positions Trend

Date	Increased Positions	Change %
30 Sep, 23	11	37.50%
30 Jun, 23	8	-11.11%
31 Mar, 23	9	12.50%
31 Dec, 22	8	300.00%
30 Sep, 22	2	-50.00%
30 Jun, 22	4	33.33%
31 Mar, 22	3	-
31 Dec, 21	3	200.00%
30 Sep, 21	1	-87.50%
30 Jun, 21	8	33.33%
31 Mar, 21	6	-

11 institutional shareholders have increased their position in NVOS stock as of 30 Sep 23 compared to 8 in the previous quarter (a 37.50% increase).

Institutional Reduced Positions Trend

Date	Reduced Positions	Change %
30 Sep, 23	2	-33.33%
30 Jun, 23	3	-25.00%
31 Mar, 23	4	100.00%
31 Dec, 22	2	-33.33%
30 Sep, 22	3	200.00%
30 Jun, 22	1	-
31 Mar, 22	-	-100.00%
31 Dec, 21	1	-50.00%
30 Sep, 21	2	100.00%
30 Jun, 21	1	-
31 Mar, 21	-	-

2 institutional shareholders have reduced their position in NVOS stock as of 30 Sep 23 compared to 3 in the previous quarter (a -33.33% decrease).

All Institutional Ownership Trend Data

Date	Holdings	Change %	Shares Outstanding	Change %	Ownership %	Change %	Increased Positions	Change %	Reduced Positions	Change %
30 Sep, 23	15	7.14%	6,271,181	185.70%	4.37%	57.05%	11	37.50%	2	-33.33%
30 Jun, 23	14	-	2,194,985	216.08%	2.77%	361.11%	8	-11.11%	3	-25.00%
31 Mar, 23	14	16.67%	694,445	-78.66%	0.88%	5.20%	9	12.50%	4	100.00%
31 Dec, 22	12	50.00%	3,254,104	632.08%	4.10%	1306.59%	8	300.00%	2	-33.33%
30 Sep, 22	8	14.29%	444,499	4.69%	0.56%	195.61%	2	-50.00%	3	200.00%
30 Jun, 22	7	40.00%	424,580	7.15%	0.54%	214.56%	4	33.33%	1	-
31 Mar, 22	5	-28.57%	396,232	-3.08%	0.50%	188.08%	3	-	-	-100.00%
31 Dec, 21	7	40.00%	408,809	1.99%	0.52%	201.88%	3	200.00%	1	-50.00%
30 Sep, 21	5	-44.44%	400,815	-33.50%	0.51%	87.52%	1	-87.50%	2	100.00%
30 Jun, 21	9	50.00%	602,771	446.76%	0.76%	3933.53%	8	33.33%	1	-
31 Mar, 21	6	-	110,244	-	0.14%	-	6	-	-	-

Novo Integrated Sciences Insider Shareholders Trades

Open Market Insider Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Apr 21, 2022	Oliva Robert Letterio	director		P-Purchase	Buy	300	$2.25	$675.00	217,717
Apr 23, 2021	Oliva Robert Letterio	director	-	P-Purchase	Buy	13,000	$2.12	$27.56K	207,717
Feb 23, 2021	Oliva Robert Letterio	director	-	P-Purchase	Buy	200	$4.45	$890.00	194,717
Feb 23, 2021	Oliva Robert Letterio	director	-	P-Purchase	Buy	9,355	$4.31	$40.32K	194,517

Open Market Insider Buys

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Apr 21, 2022	Oliva Robert Letterio	director		P-Purchase	Buy	300	$2.25	$675.00	217,717
Apr 23, 2021	Oliva Robert Letterio	director	-	P-Purchase	Buy	13,000	$2.12	$27.56K	207,717
Feb 23, 2021	Oliva Robert Letterio	director	-	P-Purchase	Buy	200	$4.45	$890.00	194,717
Feb 23, 2021	Oliva Robert Letterio	director	-	P-Purchase	Buy	9,355	$4.31	$40.32K	194,517

Insider Sells

Date	Name	Relation	Role	Buy/Sell	Shares	Price	Value	Shares Held
Feb 23, 2021	Oliva Robert Letterio	director	-	Sell	-	-	-	185,162
Feb 23, 2021	Oliva Robert Letterio	director	-	Sell	25,000	$1.60	$40.00K	-
Feb 23, 2021	Oliva Robert Letterio	director	-	Sell	19,800	$3.80	$75.24K	-
Feb 19, 2021	Pope Michael Ross	director	-	Sell	33,000	$3.80	$125.40K	-
Feb 19, 2021	Flesias Alex	director	-	Sell	19,800	$3.80	$75.24K	-
Feb 19, 2021	Oliva Robert Letterio	director	-	Sell	-	-	-	178,555
Feb 19, 2021	Oliva Robert Letterio	director	-	Sell	25,000	$1.60	$40.00K	-

All Insider Owners Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Jun 02, 2023	David Christopher Mehlin	director, officer	COO & President	A-Award	Buy	2,000,000	$0.13	$264.00K	2,000,000
Aug 10, 2022	Ali Sarfaraz	director		A-Award	Buy	39,480	-	-	39,480
Aug 10, 2022	Ali Sarfaraz	director			Buy	-	-	-	-
Apr 21, 2022	Oliva Robert Letterio	director		P-Purchase	Buy	300	$2.25	$675.00	217,717
Feb 24, 2022	Oliva Robert Letterio	director	-	A-Award	Buy	93,995	$1.33	$125.01K	93,995
Feb 24, 2022	Flesias Alex	director	-	A-Award	Buy	93,995	$1.33	$125.01K	93,995
Feb 24, 2022	Pope Michael Ross	director	-	A-Award	Buy	93,995	$1.33	$125.01K	93,995
Apr 28, 2021	Jimenez Sterling M.	officer	-		Buy	-	-	-	-
Apr 23, 2021	Oliva Robert Letterio	director	-	P-Purchase	Buy	13,000	$2.12	$27.56K	207,717
Mar 02, 2021	BRAY THOMAS EDWARD	officer	-		Buy	-	-	-	-
Feb 23, 2021	Oliva Robert Letterio	director	-	P-Purchase	Buy	200	$4.45	$890.00	194,717
Feb 23, 2021	Oliva Robert Letterio	director	-	P-Purchase	Buy	9,355	$4.31	$40.32K	194,517
Feb 23, 2021	Oliva Robert Letterio	director	-		Sell	-	-	-	185,162
Feb 23, 2021	Oliva Robert Letterio	director	-		Sell	25,000	$1.60	$40.00K	-
Feb 23, 2021	Oliva Robert Letterio	director	-		Sell	19,800	$3.80	$75.24K	-
Feb 19, 2021	Pope Michael Ross	director	-		Sell	33,000	$3.80	$125.40K	-
Feb 19, 2021	Gaynor Michael Joseph	director	-		Buy	-	-	-	1,743,713
Feb 19, 2021	Flesias Alex	director	-		Sell	19,800	$3.80	$75.24K	-
Feb 19, 2021	Oliva Robert Letterio	director	-		Sell	-	-	-	178,555
Feb 19, 2021	Oliva Robert Letterio	director	-		Sell	25,000	$1.60	$40.00K	-

The last insider sell of Novo Integrated Sciences's stock was made by Oliva Robert Letterio on Feb 23 2021, selling - shares at - per share (valued at -). The last insider buy of NVOS was made by Oliva Robert Letterio on Apr 21 2022, buying 300 shares at $2.25 per share (worth $675.00).

Novo Integrated Sciences Insider Ownership Trends

All Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q2 2023	1	-	-
Q3 2022	1	-	-
Q2 2022	1	-	-
Q1 2022	3	-	-
Q2 2021	1	-	-
Q1 2021	2	7	28.57%
Q3 2020	-	1	-
Q4 2017	-	1	-
Q2 2017	-	2	-
Q4 2007	-	10	-
Q1 2007	-	5	-
Q4 2006	1	3	33.33%
Q3 2006	2	-	-
Q2 2006	-	21	-
Q4 2005	-	-	-
Q3 2005	-	1	-
Q3 2004	-	8	-

1 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Novo Integrated Sciences's insiders, as of Q2 2023.

Open Market Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q2 2023	-	-	-
Q3 2022	-	-	-
Q2 2022	1	-	-
Q1 2022	-	-	-
Q2 2021	1	-	-
Q1 2021	2	-	-
Q3 2020	-	-	-
Q4 2017	-	-	-
Q2 2017	-	-	-
Q4 2007	-	10	-
Q1 2007	-	5	-
Q4 2006	2	2	100.00%
Q3 2006	2	-	-
Q2 2006	1	20	5.00%
Q4 2005	-	-	-
Q3 2005	-	-	-
Q3 2004	-	-	-

As of Q2 2023, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Novo Integrated Sciences's stocks.

Novo Integrated Sciences Peer Ownership

Ticker	Company
CANO	Cano Health, Inc.
LFST	LifeStance Health Group, Inc.
DVA	DaVita Inc.
AMN	AMN Healthcare Services, Inc.
BACK	IMAC Holdings, Inc.
TOI	The Oncology Institute, Inc.
BKD	Brookdale Senior Living Inc.
PNTG	The Pennant Group, Inc.
AVAH	Aveanna Healthcare Holdings Inc.
UHS	Universal Health Services, Inc.
ACHC	Acadia Healthcare Company, Inc.
THC	Tenet Healthcare Corporation
CYH	Community Health Systems, Inc.
AGL	agilon health, inc.
PIII	P3 Health Partners Inc.

NVOS Ownership FAQ

Who Owns Novo Integrated Sciences?

Novo Integrated Sciences is owned by institutional shareholders (4.37%), insiders (6.82%), and public (88.81%). The largest institutional shareholder of Novo Integrated Sciences is BANK OF AMERICA CORP /DE/ (0% of total shares) and the top mutual fund owner is Vericimetry Funds (0.06% of total shares).

Who are the major institutional shareholders of Novo Integrated Sciences?

Novo Integrated Sciences's major institutional shareholders are BANK OF AMERICA CORP /DE/, WELLS FARGO & COMPANY/MN, NORTHERN TRUST CORP, STATE STREET CORP, and VANGUARD GROUP INC. The top five shareholders own together 0% of the company's share outstanding.

How many Novo Integrated Sciences shareholders are there?

As of Sep 2023, there are 15 institutional shareholders of Novo Integrated Sciences.

What percentage of Novo Integrated Sciences is owned by BANK OF AMERICA CORP /DE/?

BANK OF AMERICA CORP /DE/ owns 0 shares of Novo Integrated Sciences, representing 0% of the company's total shares outstanding, valued at $0 (as of Dec 2023).

What percentage of Novo Integrated Sciences is owned by WELLS FARGO & COMPANY/MN?

As of Dec 2023, WELLS FARGO & COMPANY/MN holds 0 shares of Novo Integrated Sciences (NVOS), compromising 0% of the company, valued at $0.

What percentage of Novo Integrated Sciences is owned by NORTHERN TRUST CORP?

NORTHERN TRUST CORP is the third largest holder of Novo Integrated Sciences. The company owns 0 of the company's shares outstanding (worth $0).